BR9909868A - Ascorbato de paroxetina - Google Patents
Ascorbato de paroxetinaInfo
- Publication number
- BR9909868A BR9909868A BR9909868-7A BR9909868A BR9909868A BR 9909868 A BR9909868 A BR 9909868A BR 9909868 A BR9909868 A BR 9909868A BR 9909868 A BR9909868 A BR 9909868A
- Authority
- BR
- Brazil
- Prior art keywords
- paroxetine ascorbate
- paroxetine
- ascorbate
- useful
- treatment
- Prior art date
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title abstract 6
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title abstract 3
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title abstract 3
- 229940072107 ascorbate Drugs 0.000 title abstract 3
- 235000010323 ascorbic acid Nutrition 0.000 title abstract 3
- 239000011668 ascorbic acid Substances 0.000 title abstract 3
- 229960002296 paroxetine Drugs 0.000 title abstract 3
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"ASCORBATO DE PAROXETINA" O ascorbato de paroxetina é útil no tratamento de alguns distúrbios da CNS.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9808896.6A GB9808896D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
| PCT/GB1999/001244 WO1999055698A1 (en) | 1998-04-25 | 1999-04-23 | Paroxetine ascorbate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9909868A true BR9909868A (pt) | 2000-12-19 |
Family
ID=10831008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9909868-7A BR9909868A (pt) | 1998-04-25 | 1999-04-23 | Ascorbato de paroxetina |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1089995A1 (pt) |
| JP (1) | JP2002513019A (pt) |
| KR (1) | KR20010042977A (pt) |
| CN (1) | CN1297448A (pt) |
| AP (1) | AP2000001963A0 (pt) |
| AU (1) | AU3618499A (pt) |
| BG (1) | BG104940A (pt) |
| BR (1) | BR9909868A (pt) |
| CA (1) | CA2330055A1 (pt) |
| EA (1) | EA200001104A1 (pt) |
| GB (1) | GB9808896D0 (pt) |
| HU (1) | HUP0102116A3 (pt) |
| ID (2) | ID26083A (pt) |
| IL (1) | IL139081A0 (pt) |
| NO (1) | NO20005352D0 (pt) |
| PL (1) | PL343677A1 (pt) |
| SK (1) | SK15912000A3 (pt) |
| TR (1) | TR200003084T2 (pt) |
| WO (1) | WO1999055698A1 (pt) |
| ZA (1) | ZA200005912B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
| IL159280A0 (en) * | 2001-06-14 | 2004-06-01 | Teva Pharma | A process for preparing paroxetine hcl which limits formation of pink colored compounds |
| JP4508646B2 (ja) | 2002-01-09 | 2010-07-21 | エミスフェアー・テクノロジーズ・インク | ４−［（４−クロロ−２−ヒドロキシベンゾイル）アミノ］ブタン酸ナトリウムの多形体 |
| CN110607555B (zh) * | 2018-10-30 | 2024-02-20 | 中国科学院化学研究所 | 一种制备紫杉醇单晶或无定型物的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| ES2058061T3 (es) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
| US5276042A (en) * | 1993-04-16 | 1994-01-04 | Crenshaw Roger T | Treatment of premature ejaculation |
| ES2117557B1 (es) * | 1996-02-29 | 1999-07-01 | Ferrer Int | Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina. |
-
1998
- 1998-04-25 GB GBGB9808896.6A patent/GB9808896D0/en not_active Ceased
-
1999
- 1999-04-23 SK SK1591-2000A patent/SK15912000A3/sk unknown
- 1999-04-23 IL IL13908199A patent/IL139081A0/xx unknown
- 1999-04-23 EP EP99918151A patent/EP1089995A1/en not_active Withdrawn
- 1999-04-23 ID IDW20002168A patent/ID26083A/id unknown
- 1999-04-23 TR TR2000/03084T patent/TR200003084T2/xx unknown
- 1999-04-23 BR BR9909868-7A patent/BR9909868A/pt not_active Application Discontinuation
- 1999-04-23 PL PL99343677A patent/PL343677A1/xx not_active Application Discontinuation
- 1999-04-23 KR KR1020007011809A patent/KR20010042977A/ko not_active Withdrawn
- 1999-04-23 HU HU0102116A patent/HUP0102116A3/hu unknown
- 1999-04-23 CA CA002330055A patent/CA2330055A1/en not_active Abandoned
- 1999-04-23 WO PCT/GB1999/001244 patent/WO1999055698A1/en not_active Ceased
- 1999-04-23 CN CN99805160A patent/CN1297448A/zh active Pending
- 1999-04-23 EA EA200001104A patent/EA200001104A1/ru unknown
- 1999-04-23 ID IDW20002169A patent/ID26654A/id unknown
- 1999-04-23 JP JP2000545858A patent/JP2002513019A/ja active Pending
- 1999-04-23 AU AU36184/99A patent/AU3618499A/en not_active Abandoned
- 1999-04-23 AP APAP/P/2000/001963A patent/AP2000001963A0/en unknown
-
2000
- 2000-10-23 ZA ZA200005912A patent/ZA200005912B/en unknown
- 2000-10-24 NO NO20005352A patent/NO20005352D0/no not_active Application Discontinuation
- 2000-11-13 BG BG104940A patent/BG104940A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL343677A1 (en) | 2001-08-27 |
| BG104940A (bg) | 2001-09-28 |
| NO20005352L (no) | 2000-10-24 |
| ID26654A (id) | 2001-01-25 |
| CN1297448A (zh) | 2001-05-30 |
| ID26083A (id) | 2000-11-23 |
| CA2330055A1 (en) | 1999-11-04 |
| NO20005352D0 (no) | 2000-10-24 |
| SK15912000A3 (sk) | 2001-04-09 |
| WO1999055698A1 (en) | 1999-11-04 |
| AU3618499A (en) | 1999-11-16 |
| ZA200005912B (en) | 2001-12-19 |
| AP2000001963A0 (en) | 2000-12-31 |
| HUP0102116A2 (hu) | 2002-05-29 |
| TR200003084T2 (tr) | 2001-02-21 |
| EP1089995A1 (en) | 2001-04-11 |
| JP2002513019A (ja) | 2002-05-08 |
| IL139081A0 (en) | 2001-11-25 |
| GB9808896D0 (en) | 1998-06-24 |
| HUP0102116A3 (en) | 2002-12-28 |
| EA200001104A1 (ru) | 2001-04-23 |
| KR20010042977A (ko) | 2001-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2018020I1 (el) | Θεραπεια της νοσου ρομρε | |
| IT244967Y1 (it) | Ortesi dinamica per il trattamento conservativo dell'instabilita'femoro-rotulea del ginocchio | |
| ES2191102T3 (es) | Heterociclos de peptidilo utiles en el tratamiento de las afecciones relacionadas con la trombina. | |
| CH1143977H1 (fr) | 2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite | |
| TR200000059T2 (tr) | Piridin türevleri | |
| TR200002773T2 (tr) | Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı. | |
| NO20005884L (no) | Kombinasjonsterapi for behandling av bipolare forstyrrelser | |
| ES2184077T3 (es) | Nuevas fenantridinas sustituidas en la posicion 6. | |
| FI972919A0 (fi) | Indolijohdannaisia jotka ovat käyttökelpoisia osteoporoosin hoidossa | |
| NO20005885D0 (no) | Kombinasjonsterapi for behandling av refraktær depresjon | |
| NO20001869D0 (no) | Fremgangsmõte for behandling av Alzheimerssykdom | |
| FI974640A7 (fi) | Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit | |
| ID27214A (id) | Triazolopiridina untuk pengobatan gangguan trombosis | |
| FI971127A7 (fi) | 2,4-diaminopyrimidiini-3-oksidin tai jonkin sen suolan käyttö kollagee nin kypsymis- ja rakentumishäiriöiden hoitamiseen | |
| DE58902899D1 (de) | 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer. | |
| TR200000455T2 (tr) | Alzheimer hastalığının tedavisinde fankinonun kullanılması. | |
| DE69735417D1 (de) | 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen | |
| BR0012921A (pt) | Compostos calcilìticos | |
| BR9909868A (pt) | Ascorbato de paroxetina | |
| NO990450D0 (no) | Behandling av sinnslidelser | |
| NO20011892D0 (no) | 3-tetrahydropyridin-4-yl-indoler for behandling av psykotiske forstyrrelser | |
| DE69917445D1 (de) | Reinigung von carboxaldehyd | |
| NO20012612D0 (no) | Isonipecotamider for behandling av integren-formidlede lidelser | |
| EE200200670A (et) | S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks | |
| AP2000001958A0 (en) | Paroxetine 10-camphorsulfornate for treatment of CNS disorders. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |